The cost-utility of calcipotriol/bethamethasone (Dovobet) ointment in the treatment of psoriasis vulgaris in the United Kingdom

被引：6
|
作者：
Noerregaard, J
Lowson, D
机构：
[1] Leo Pharmaceut Prod, DK-2750 Ballerup, Denmark
[2] Leo Pharmaceut Prod, Princes Risborough, Bucks, England
来源：
VALUE IN HEALTH | 2003年 / 6卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)61998-5
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：785 / 785
页数：1
相关论文
共 50 条
  • [1] A Cost-utility Analysis of Calcipotriol/Betamethasone Dipropionate Aerosol Foam versus Ointment for the Topical Treatment of Psoriasis Vulgaris in Sweden
    Duvetorp, Albert
    Levin, Lars-Ake
    Engerstedt Mattsson, Emma
    Ryttig, Lasse
    ACTA DERMATO-VENEREOLOGICA, 2019, 99 (04) : 393 - 399
  • [2] Calcipotriol-betamethasone ointment versus calcipotriol ointment in the treatment of psoriasis vulgaris
    Duweb, G
    Alhaddar, J
    Elsherif, B
    Eljehawi, N
    Makhlouf, H
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 2005, 31 (5-6) : 175 - 179
  • [3] Successful treatment of scalp psoriasis with Dovobet® ointment
    Emerson, RM
    Howlett, C
    BRITISH JOURNAL OF DERMATOLOGY, 2004, 151 : 52 - 53
  • [4] Calcipotriol ointment versus cream in psoriasis vulgaris
    Duweb, G
    Aldebani, S
    Elzorghany, A
    Benghazil, M
    Alhaddar, J
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 2003, 23 (2-3) : 47 - 51
  • [5] Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris
    Kragballe, K
    Noerrelund, KL
    Lui, H
    Ortonne, JP
    Wozel, G
    Uurasmaa, T
    Fleming, C
    Estebaranz, JLL
    Hanssen, LI
    Persson, LM
    BRITISH JOURNAL OF DERMATOLOGY, 2004, 150 (06) : 1167 - 1173
  • [6] A COST-UTILITY ANALYSIS OF LIGHTERLIFE TOTAL AS A TREATMENT FOR OBESITY IN THE UNITED KINGDOM
    Lewis, L.
    Taylor, M.
    VALUE IN HEALTH, 2013, 16 (07) : A385 - A385
  • [7] Evaluation of the cost-utility of orlistat (Xenical) in the United Kingdom
    McEwan, P
    Jones, M
    Farina, C
    Currie, CJ
    VALUE IN HEALTH, 2004, 7 (06) : 721 - 721
  • [8] Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet®) versus calcipotriol (Daivonex®) in the treatment of psoriasis vulgaris:: A randomized, multicentre, clinical trial
    Saraceno, Rosita
    Andreassi, Lucio
    Ayala, Fabio
    Bongiorno, Maria Rita
    Giannetti, Alberto
    Lisi, Paolo
    Martini, Patrizia
    Peris, Ketty
    Peserico, Andrea
    Chimenti, Sergio
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2007, 18 (06) : 361 - 365
  • [9] COST-UTILITY EVALUATION COMPARING DISEASE PROGRESSION IN MODERATE VERSUS SEVERE PSORIASIS IN ADULTS IN THE UNITED KINGDOM
    Szewczenko, I
    Jackson, D.
    Thompson, P.
    Betts, A.
    VALUE IN HEALTH, 2020, 23 : S595 - S595
  • [10] Influenza treatment with neuraminidase inhibitors: Cost-effectiveness and cost-utility in healthy adults in the United Kingdom
    Sander B.
    Gyldmark M.
    Hayden F.G.
    Morris J.
    Mueller E.
    Bergemann R.
    The European Journal of Health Economics, 2005, 6 (3) : 244 - 252
12345